Segments in CHF m

 

 

Care Chemicals

 

Catalysis

 

Natural Resources

 

Plastics & Coatings

 

Corporate

 

Total Group

 

 

2016

 

2015

 

2016

 

2015

 

2016

 

2015

 

2016

 

2015

 

2016

 

2015

 

2016

 

2015

1

EBITDA is earning before interest, tax, depreciation and amortization.

Segment sales

 

1 473

 

1 446

 

673

 

704

 

1 190

 

1 219

 

2 547

 

2 458

 

 

 

5 883

 

5 827

Sales to other segments

 

–8

 

–1

 

 

 

–6

 

–2

 

–22

 

–17

 

 

 

–36

 

–20

Total sales

 

1 465

 

1 445

 

673

 

704

 

1 184

 

1 217

 

2 525

 

2 441

 

 

 

5 847

 

5 807

Operating expenses

 

–1 254

 

–1 225

 

–571

 

–565

 

–1 039

 

–1 044

 

–2 256

 

–2 230

 

–215

 

–247

 

–5 335

 

–5 311

Thereof:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from associates and joint ventures

 

9

 

9

 

13

 

18

 

12

 

9

 

34

 

30

 

17

 

11

 

85

 

77

Gain/loss from disposals not qualifying as discontinued operations

 

 

 

 

12

 

 

3

 

–2

 

 

–1

 

 

–3

 

15

Restructuring, impairment and transaction-related costs

 

–10

 

–6

 

–11

 

 

–14

 

–1

 

–18

 

–23

 

–54

 

–85

 

–107

 

–115

Operating income

 

211

 

220

 

102

 

139

 

145

 

173

 

269

 

211

 

–215

 

–247

 

512

 

496

Net financial expenses and taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–249

 

–269

Net result from continuing operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

263

 

227

Result from discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

263

 

239

Segment assets

 

1 096

 

982

 

1 673

 

1 631

 

1 296

 

872

 

1 693

 

1 700

 

 

 

 

 

5 758

 

5 185

Segment liabilities

 

–206

 

–200

 

–95

 

–123

 

–135

 

–109

 

–249

 

–228

 

 

 

 

 

–685

 

–660

Net operating assets

 

890

 

782

 

1 578

 

1 508

 

1 161

 

763

 

1 444

 

1 472

 

 

 

5 073

 

4 525

Net assets held for sale

 

 

 

5

 

 

 

 

2

 

2

 

 

 

7

 

2

Corporate assets without cash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 275

 

1 333

 

1 275

 

1 333

Corporate liabilities without financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–2 269

 

–2 054

 

–2 269

 

–2 054

Net debt (see note 18)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–1 540

 

–1 312

 

–1 540

 

–1 312

Total net assets

 

890

 

782

 

1 583

 

1 508

 

1 161

 

763

 

1 446

 

1 474

 

–2 534

 

–2 033

 

2 546

 

2 494

Thereof:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in PPE and intangibles for the period

 

79

 

97

 

87

 

148

 

40

 

33

 

82

 

78

 

48

 

45

 

336

 

401

Investments in associates and joint ventures at the end of the period

 

56

 

57

 

193

 

187

 

14

 

15

 

148

 

143

 

105

 

184

 

516

 

586

Reconciliation of key figures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

211

 

220

 

102

 

139

 

145

 

173

 

269

 

211

 

–215

 

–247

 

512

 

496

Add: systematic depreciation of PPE

 

49

 

42

 

30

 

33

 

27

 

24

 

69

 

68

 

35

 

36

 

210

 

203

Add: impairment

 

 

 

5

 

 

 

 

3

 

13

 

 

1

 

8

 

14

Add: amortization of intangible assets

 

6

 

4

 

17

 

17

 

14

 

11

 

10

 

11

 

8

 

11

 

55

 

54

EBITDA1

 

266

 

266

 

154

 

189

 

186

 

208

 

351

 

303

 

–172

 

–199

 

785

 

767

Add: restructuring, impairment and transaction-related costs

 

10

 

6

 

11

 

 

14

 

1

 

18

 

23

 

54

 

85

 

107

 

115

Less: impairment

 

 

 

–5

 

 

 

 

–3

 

–13

 

 

–1

 

–8

 

–14

Less: gain/loss from disposals not qualifying as discontinued operations

 

 

 

 

–12

 

 

–3

 

2

 

 

1

 

 

3

 

–15

EBITDA before exceptional items

 

276

 

272

 

160

 

177

 

200

 

206

 

368

 

313

 

–117

 

–115

 

887

 

853

Operating income

 

211

 

220

 

102

 

139

 

145

 

173

 

269

 

211

 

–215

 

–247

 

512

 

496

Add: restructuring, impairment and transaction-related costs

 

10

 

6

 

11

 

 

14

 

1

 

18

 

23

 

54

 

85

 

107

 

115

Less: gain/loss from disposals not qualifying as discontinued operations

 

 

 

 

–12

 

 

–3

 

2

 

 

1

 

 

3

 

–15

Operating income before exceptional items

 

221

 

226

 

113

 

127

 

159

 

171

 

289

 

234

 

-160

 

-162

 

622

 

596